,text,is_bold,is_italic,is_underlined,left,right,top,bottom,detected_as_title
0,Employee Involvement,True,False,False,77.9,175.6,425.3,434.2,True
1,Income Taxes,True,True,False,33.1,79.6,284.8,290.6,True
2, ,False,False,False,77.9,81.3,346.1,355.0,False
3,the Audit & Remuneration Committee,False,True,False,124.8,247.3,380.3,385.9,True
4,Industry Overview,True,False,False,33.1,93.5,266.5,272.0,True
5,Lonza Agreement,True,True,False,112.4,169.8,307.3,313.1,True
6,Statement of directors' responsibilities,True,False,False,68.0,298.6,119.6,132.1,False
7,Interest payable,True,False,False,54.1,139.9,368.6,376.2,True
8,"We are dependent on our third party manufacturers to conduct process development and scale-up work necessary to support greater clinical development and commercialization requirements for our product candidates. Carrying out these activities in a timely manner, and on commercially reasonable terms, is critical to the successful development and commercialization of our product candidates. We expect that our third-party manufacturers are capable of providing sufficient quantities of our product candidates to meet anticipated clinical and full-scale commercial demands, however if third parties with whom we currently work are unable to meet our supply requirements, we will need to secure alternate suppliers. While we believe that there are other contract manufacturers having the technical capabilities to manufacture our product candidates, we cannot be certain that identifying and establishing relationships with such sources would not result in significant delay or material additional costs.",False,False,False,112.4,720.7,222.9,266.9,False
9,-,False,False,False,125.0,130.0,362.3,370.4,False
10,"There were no changes in our internal controls over financial reporting during the quarter ended December 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.",False,False,False,112.4,725.0,76.6,89.9,False
11,"Income tax provision (benefit) - Our effective tax rate was 58% for fiscal 2015 compared with 54% for the prior year. The current year rate reflects the benefit of the $9.2 million nontaxable adjustment to the contingent liabilities related to Vortex Medical and Clinical Devices, and a seven month benefit from the R&D tax credit that expired on December 31, 2014, offset by non-deductible interest expense related to contingent payments, true-ups of our fiscal year 2014 US income tax returns and the impact of the elimination of the ASC 718 APIC pool. The prior year rate reflects the benefit of the $5.0 million nontaxable adjustment to the contingent liability related to Vortex Medical, Inc., offset by the impact of a New York State tax law change that resulted in a $1.2 million net write off of tax assets, non-deductible interest expense related to contingent payments, a seven month benefit from the R&D tax credit that expired on December 31, 2013, true ups of our fiscal year 2013 US income tax returns and the impact of the elimination of the ASC 718 APIC pool.",False,False,False,33.1,806.7,217.7,259.4,False
12,failure to meet or exceed the estimates and projections of the investment community;,False,False,False,140.2,405.9,338.3,343.9,False
13,Client Subscription Growth,False,False,False,34.3,120.6,368.4,374.1,True
14,2. Other Percentages 2 Feb 2015 3 Feb 2014 As a percentage of shares and borrowings:- Gross Capital 7.54% 7.30% Free Capital 6.70% 6.40% Liquid Assets 29.22% 24.83% As a percentage of mean total assets:- Profit after taxation 0.73% 0.85% Management Expenses 1.25% 1.20% Cost/Income 66.45% 66.93%,False,False,False,51.0,545.6,359.1,494.9,False
15,"2015 2014 Assets Note     Liquid assets Cash in hand 224,585 261,362 Treasury bills 11 1,998,581 - Loans and advances to credit institutions 10 59,220,095 48,242,675 Loans and advances to customers Loans fully secured on residential property 13 161,811,466 158,392,619 Other loans - fully secured on land 13 1,110,976 1,233,016 Investments 14 184,252 184,252 Tangible fixed assets 15 1,903,339 1,900,832 Other assets 16 49,435 41,292 Prepayments and accrued income 17 290,479 272,884 Total Assets 226,793,208 210,528,932 Liabilities Shares 18 199,171,349 186,722,693 Amounts owed to credit institutions 19 5,506,919 3,510,820 Amounts owed to other customers 20 5,574,783 5,076,486 Other liabilities 21 234,140 562,133 Accruals and deferred income 22 248,764 200,418 Provision for liabilities and charges 6 197,162 200,946 210,933,117 196,273,496 General reserves 24 15,860,091 14,255,436 Total Liabilities 226,793,208 210,528,932",False,False,False,51.0,545.7,117.7,626.9,False
16,Expenditures relating to research and development are expensed in the period incurred. Research and development expenses consist of both internal and external costs associated with the development of the Company's selective cancer therapies and building of its discovery platform.,False,False,False,112.9,725.1,157.7,171.2,False
17,BAC grants equity based payment awards to employees of the Company under various incentive schemes.,False,False,False,125.6,550.7,479.5,497.1,False
18,"The investigator-initiated PLATFORM Phase 2 study in gastroesophageal cancer in the first-line maintenance setting, which is expected to initiate during the first quarter of 2017.",False,False,False,140.2,698.8,236.5,242.1,False
19,Financial Statements and Supplementary Data.,True,True,False,78.7,235.7,163.5,169.4,False
20,"On September 17, 2014, we acquired Tri-Ed, a leading independent distributor of security and low-voltage technology products, from Tri-NVS Holdings, LLC for $418.4 million. A portion of the proceeds from a subsequent issuance of $400.0 million principal amount of senior notes were used to repay certain incurred borrowings to finance the Tri-Ed acquisition.",False,False,False,33.1,809.0,291.6,306.2,False
21,"Changes in competitors' production, geographic or marketing focus could have a material impact on our business. We face global competition from new and existing competitors who have entered or may enter the markets in which we sell. Some of our competitors may have greater financial and other resources than we do or are more diversified, making them less vulnerable to industry downturns and better positioned to pursue new expansion and development opportunities. Our competitive position could suffer if we are unable to expand our operations through investments in new or existing operations or through acquisitions, joint ventures or partnerships.",False,False,False,33.1,808.6,354.0,377.7,False
22,Shares are repayable from the balance sheet date in the ordinary course of business as follows:,False,False,False,42.6,424.1,597.8,605.9,True
23,"The Company formally documents its hedge relationships, including the identification of the hedging instruments and the hedged items, as well as its risk management objectives and strategies for undertaking the cash flow hedges. The Company also formally assesses whether a cash flow hedge is highly effective in offsetting changes in the cash flows of the hedged item. Derivatives are recorded at fair value in other current assets, accrued liabilities and other long-term liabilities. The Company is exposed to credit risk in the event of nonperformance by its counterparties on its derivative financial instruments. The Company mitigates this credit risk exposure by entering into agreements directly with major financial institutions with high credit standards that are expected to fully satisfy their obligations under the contracts.",False,False,False,33.1,807.5,62.3,94.9,False
24,"As of February 16, 2017, we employed 278 full-time employees. None of our employees is represented by labor unions, and a very small number of international employees are covered by collective bargaining agreements. We consider our relationship with our employees to be good.",False,False,False,112.4,705.0,145.9,159.1,False
25,"The sale of the Bank continues to progress as expected, with an anticipated close on or around 31 October 2016.",False,False,False,107.4,498.8,359.6,381.2,False
26,Controlling party,True,False,False,96.3,171.6,727.1,736.0,False
27,Attract and retain good people that share our values;,False,False,False,63.9,268.6,310.3,318.5,True
28,Independent Auditors,True,False,False,77.9,171.9,623.9,632.8,True
29,Other Logistics Services,False,True,True,112.9,183.3,370.8,376.5,True
30,"We adopted Accounting Standards Update (""ASU"") 2015-17, Balance Sheet Classification of Deferred Taxes, and ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs, on January 1, 2016 and prior period amounts have been reclassified to conform to the current period presentation. See Recently Issued Accounting Pronouncements section in Note 1 for additional information.",False,False,False,33.1,808.7,399.6,414.3,False
31,"Page Report of Independent Registered Public Accounting Firm - Internal Control Over Financial Reporting 42 Report of Independent Registered Public Accounting Firm - Consolidated Financial Statements 43 Consolidated Statements of Income 44 Consolidated Statements of Comprehensive (Loss) Income 45 Consolidated Balance Sheets 46 Consolidated Statements of Equity 47 Consolidated Statements of Cash Flows 48 Notes to Consolidated Financial Statements 49 Note 1. Organization and Nature of Operations 49 Note 2. Summary of Significant Accounting Policies 49 Note 3. Recently Issued Accounting Pronouncements 55 Note 4. Acquisitions 56 Note 5. Net Income Per Share 57 Note 6. Income Taxes 58 Note 7. Goodwill and Intangible Assets 61 Note 8. Property, Plant and Equipment, Net 62 Note 9. Inventories, Net 62 Note 10. Debt 63 Note 11. Equity 64 Note 12. Accrued Liabilities 69 Note 13. Defined Benefit Plans 72 Note 14. Financial Instruments and Fair Value Measurements 78 Note 15. Commitments and Contingencies 81 Note 16. Segment Information 84 Note 17. Selected Quarterly Data-(unaudited) 87",False,False,False,34.3,806.1,82.8,401.1,False
32,Property and equipment Intangible assets,False,False,False,61.9,138.6,378.6,395.1,True
33, ,False,False,False,47.5,50.3,298.8,304.4,False
34,b.,True,False,False,77.9,85.9,514.9,523.8,False
35,"The following table provides a reconciliation of benefit obligations, plan assets and funded status based on a December 31 measurement date:",False,False,False,61.9,514.8,350.3,356.0,False
36,"We make available, free-of-charge through our website, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file or furnish such materials to the Securities and Exchange Commission, or SEC. In addition, our website includes, among other things, charters of the various committees of our Board of Directors and our code of business conduct and ethics applicable to all employees, officers and directors. Any stockholder also may obtain copies of these documents, free of charge, by sending a request in writing to our investor relations firm: FTI Consulting, 88 Pine Street, 32nd Floor New York, NY 10005, Attention: Evan Smith. Information on our website or connected to our website is not incorporated by reference into this annual report on Form 10-K.",False,False,False,33.1,798.9,48.4,385.5,False
37,Executive Directors' Remuneration,True,False,False,51.0,216.9,327.3,336.4,True
38,"IFRS 15 establishes a comprehensive framework for determining whether, how much and when revenue is recognised. The new standard does not impact the timing or measurement of the Company's revenue recognition as it is consistent with the Company's existing accounting for contracts within the scope of the new standard. The Company's presentation of certain costs, which are primarily related to underwriting activities, will be presented as operating expenses under the new standard rather than presented net in investment banking fee income. The new accounting standard does not have a material impact on the Company's income statement or statement of financial position.",False,False,False,123.8,552.9,654.6,739.2,False
39,(Dollar amounts in thousands except per share and share amounts),False,False,False,314.3,527.7,47.8,53.5,False
40,The accompanying notes are an integral part of these financial statements.,False,False,False,28.3,324.5,734.5,743.4,True
41,"The Risk Management Committee takes a strategic overview of risk and has prime responsibility for Bank Leumi (UK) group's risk management structure and strategy. This includes the annual assessment of the Bank's overall risk appetites; the identification, management and apportionment of risk to relevant risk owners; and the review and agreement of the regular group assessments of compliance, fraud and embezzlement and legal risks. The Bank has three other risk management committees which formulate the relevant strategies and policies for risks emanating from their areas of responsibility.",False,False,False,51.0,279.6,195.9,289.5,False
42,2. Summary of Significant Accounting Policies,True,False,False,33.1,186.3,111.6,117.1,False
43,Mary Reilly joined the Board in October 2015. She is a member of Crown Agents Limited Board and a member of the Council of Crown Agents Foundation. Mary is chair of the group Audit and Risk Committee. She was formerly an audit partner with Deloitte and chaired the CBI London Regional Council and the London Development Agency.,False,False,False,51.0,544.1,501.9,550.5,False
44,"In the first quarter of 2014, the Venezuelan government changed its policies regarding the bolivar, which required us to use the Complementary System for the Administration of Foreign Currency (""SICAD"") rate of 49.0 bolivars to one USD to repatriate cash from Venezuela. In the first quarter of 2014, the Argentine peso was devalued from 6.5 pesos to one USD to approximately 8.0 peso to one USD after the central bank scaled back its intervention in a bid to preserve USD cash reserves. As a result of these devaluations, we recorded foreign exchange losses in these two countries of $8.0 million in the first quarter of 2014.",False,False,False,33.1,809.3,192.5,216.2,False
45,The following table details information on the Company's segments:,False,False,False,57.7,276.1,62.3,67.9,False
46,"The fiscal 2015 provision for income taxes was $92.7 million, up from $91.9 million in fiscal 2014. The 0.9% increase was due to a 10.0% increase in pre-tax income offset by the reenactment of the U.S. Federal R&D tax credit in December 2014. The reenactment of the credit was retroactive to January 1, 2014 and extended through the end of the 2014 calendar year. The reenactment resulted in a discrete income tax benefit of $5.1 million during fiscal 2015. Additionally, we recognized tax benefits of $3.7 million related to finalizing prior year tax returns and other discrete tax items.",False,False,False,34.3,808.5,386.4,411.3,False
47,"In addition, if the market for technology stocks, or the stock market in general, experiences a loss of investor confidence, the trading price of our common stock could decline for reasons unrelated to our business, financial condition, or results of operations. If any of the foregoing occurs, it could cause our stock price to fall and may expose us to lawsuits that, even if unsuccessful, could be costly to defend and a distraction to management.",False,False,False,33.1,801.1,149.3,164.5,False
48,"Inspirational behaviour - putting people first with humanity, decency, warmth and care",False,False,False,62.4,279.9,857.5911823999999,876.2911823999999,True
49,"Capital Lease Year Ending December 31, Commitments 2017 $ 508 2018 231 Less - interest on capital leases 21 $ 718",False,False,False,157.3,681.3,399.3,451.5,False
